Company / EPS (Diluted)
Allogene Therapeutics, Inc. EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.32
FY2025
5-year range
-$2.09 / -$1.32
FY2021-FY2025
Trend
+36.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 5 years, ranging from $-2.09 in FY2024 to $-1.32 in FY2025.
Based on SEC 10-K filings.
-1.32 in FY2025.
Remained stable around $-1.32 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 36.8% year-over-year.
- Lowest eps (diluted) in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.32 | +36.8% |
| FY2024 | -$2.09 | -56.0% |
| FY2023 | -$1.34 | +35.6% |
| FY2022 | -$2.08 | -13.7% |
| FY2021 | -$1.83 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026